Lyme disease serology in amyotrophic lateral sclerosis

Muscle and Nerve

Volumn 40, Issue 4, 2009, Pages 626-628

  Qureshi, Muddasir ^a   Bedlack, Richard S ^b   Cudkowicz, Merit E ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Amyotrophic lateral sclerosis; Borrelia burgdorferi; Lyme disease; Motor neuron disease; Neuroborreliosis; Neuromuscular disease; Serology

Indexed keywords

CEFTRIAXONE;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BORRELIA BURGDORFERI; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROLOGY; UNITED STATES;

AGE OF ONSET; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTI-BACTERIAL AGENTS; BLOTTING, WESTERN; CEFTRIAXONE; COHORT STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LYME DISEASE; MALE; MASSACHUSETTS; MIDDLE AGED;

EID: 70349311332     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21438     Document Type: Article

References (14)

1. Asch E, Bujak D, Weiss M, Peterson M, Weinstein A. Lyme disease: an infectious and postinfectious syndrome. J Rheumatol 1994;21:454-461. (Pubitemid 24102829)
2. Murphree B, Kugeler K, Mead P. Surveillance for lyme disease - United States 1999 to 2006. Atlanta, GA: CDC; 2008.
3. Barbour AG, Fish D. The biological and social phenomenon of Lyme disease. Science 1993;260:1610-1616. (Pubitemid 23247141)
4. Logigian E, Kaplan R, Steere A. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323:1438-1444. (Pubitemid 20384951)
5. Hansel Y, Ackerl M, Stanek G. ALS-like sequelae in chronic neuroborreliosis. Wien Med Wochenschr 1995;145:186-188.
6. Halperin J, Kaplan G, Brazinsky S, Tsai T, Cheng T, Ironside A, et al. Immunologic reactivity against Borrelia burgdorferi in patients with motor neuron disease. Arch Neurol 1990;47:586-594. (Pubitemid 20155850)
7. Halperin J, Logigian E, Finkel M, Pearl R. Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease). Neurology 1996;46:619-627. (Pubitemid 26099622)
8. Trevejo R, Krause P, Schriefer M, Dennis D. Evaluation of two-test serodiagnostic method for lyme disease in a seroepidemiologic study in an endemic area. Am J Trop Med Hyg 2001;65:563-566. (Pubitemid 33134593)
9. Dressler F, Whalen J, Reinhardt B, Steere A. Western blotting in the serodiagnosis of lyme disease. J Infect Dis 1993;167:392-400. (Pubitemid 23036442)
10. CDC. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. Atlanta, GA: CDC; 1995.
11. Feder H, Johnson B, O'Connell S, Shapiro E, Steere A, Wormser G. A critical appraisal of "chronic Lyme disease." N Engl J Med 2007;357:1422-1430.
12. CDC.Surveillance for Lyme disease - United States, 1992-1998. Morbid Mortal Wkly Rep 2000;49:1-11.
13. Waisbren B, Cashman N, Schell R, Johnson R. Borrelia burgdorferi antibodies and amyotrophic lateral sclerosis. Lancet 1987;ii:332-333. (Pubitemid 17104228)
14. Mandell H, Steere A, Reinhardt B, Yoshinari N, Munsat T, Brod S, et al. Lack of antibodies to Borrelia burgdorferi in patients with amyotrophic lateral sclerosis. N Engl J Med 1989;320:255-256. (Pubitemid 19034158)